Bacteroidaceae in Thromboembolic Disease: Effects of Cell Wall Components on Blood Coagulation In Vivo and In Vitro

H. S. Bjornson; E. O. Hill

首页> 外文期刊>Infection and immunity >Bacteroidaceae in Thromboembolic Disease: Effects of Cell Wall Components on Blood Coagulation In Vivo and In Vitro

【24h】

Bacteroidaceae in Thromboembolic Disease: Effects of Cell Wall Components on Blood Coagulation In Vivo and In Vitro

机译：血栓栓塞性疾病中的拟杆菌科：细胞壁成分对体内和体外血液凝固的影响

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

The effects of Bacteroides sp., Fusobacterium mortiferum, Bacteroides fragilis, and Sphaerophorus necrophorus on various parameters of blood coagulation in vivo and in vitro were determined and compared to the coagulation effects of Escherichia coli and Salmonella minnesota, wild type and R595. Intravenous injection of washed cells, culture filtrate, lipopolysaccharide, or lipid A of the anaerobic gram-negative microorganisms into mice resulted in acceleration of coagulation. Lipopolysaccharide and lipid A of the anaerobic microorganisms had no apparent effect on circulating platelets in mice or rabbits and did not cause aggregation of human platelets in vitro. Washed cells, lipopolysaccharide, and lipid A of Bacteroides sp. and F. mortiferum also significantly accelerated the clotting time of recalcified platelet poor normal human plasma and C6-deficient rabbit plasma. Lipid A, but not lipopolysaccharide, of E. coli and washed cells of S. minnesota R595 accelerated coagulation by a similar mechanism. These results indicated that Bacteroides sp. and F. mortiferum can accelerate blood coagulation in vivo and in vitro by a mechanism which does not involve platelets or terminal components of complement.

机译：确定了拟杆菌菌，桑氏融合杆菌，脆弱拟杆菌和 Sphaerophorus necrophorus 对体内和体外凝血参数的影响并与大肠杆菌和明尼苏达沙门氏菌，野生型和R595的凝血效果进行了比较。将清洗过的细胞，培养物滤液，脂多糖或厌氧革兰氏阴性微生物的脂质A静脉内注入小鼠体内，加速了凝血。厌氧微生物的脂多糖和脂质A对小鼠或兔子的循环血小板没有明显影响，并且在体外不会引起人血小板的聚集。洗涤后的细菌 Bacteroides sp。的细胞，脂多糖和脂质A。和 F。 mortiferum 还显着加快了重新钙化的血小板正常人血浆和C6缺乏兔血浆的凝血时间。 E的脂类A，而不是脂多糖。大肠杆菌和洗涤过的 S细胞。明尼苏达州的R595通过类似的机制促进了凝血。这些结果表明拟杆菌 sp。和 F。 mortiferum 可以通过不涉及血小板或补体末端成分的机制促进体内和体外的凝血。 展开▼

著录项

来源
《Infection and immunity》 |1973年第6期|共8页

作者
H. S. Bjornson; E. O. Hill;
展开▼

作者单位

展开▼

收录信息

原文格式 PDF

正文语种

中图分类医学免疫学;

关键词

相似文献

外文文献

中文文献

专利

1. Evaluation of toxicity of functionalized graphene oxide with ginsenoside Rh2, lysine and arginine on blood cancer cells (K562), red blood cells, blood coagulation and cardiovascular tissue: In vitro and in vivo studies [J] . Zare-Zardini Hadi, Taheri-Kafrani Asghar, Ordooei Mahtab, Journal of the Taiwan Institute of Chemical Engineers . 2018,第期

机译：与人参皂苷RH2，赖氨酸和精氨酸毒性氧化石墨烯氧化物的毒性评价（K562），红细胞，血液凝血和心血管组织：体外和体内研究

2. In vitro and in vivo study of hazardous effects of Ag nanoparticles and Arginine-treated multi walled carbon nanotubes on blood cells: Application in hemodialysis membranes [J] . Zare-Zardini Hadi, Amiri Ahmad, Shanbedi Mehdi, Journal of biomedical materials research, Part A . 2015,第9期

机译：银纳米颗粒和精氨酸处理的多壁碳纳米管对血细胞的危害的体外和体内研究：在血液透析膜中的应用

3. Extended storage of whole blood before the preparation of blood components: in vitro effects on red blood cells in Erythro-Sol environment. [J] . Gulliksson H, Vesterinen M, Payrat JM, Vox Sanguinis: International Journal of Blood Transfusion and Immunohaematology . 2009,第3期

机译：在准备血液成分之前，应将全血长时间保存：在Erythro-Sol环境中对红细胞的体外影响。

4. Anti-Newcastle Disease Virus Effects of Echinacea Purpurea Formula in vitro and in vivo: Anti-Newcastle Disease Effects of Echinacea Purpurea Formula [C] . Shi-Ning Guo, Xue-Lian Tang, Da-You Shi, International Conference on Remote Sensing, Environment and Transportation Engineering . 2011

机译：Echinacea purpurea公式在体外和体内抗染料疾病病毒效应：抗纽卡斯尔疾病的抗染素疾病症状

5. Colonization of rice straw (Oryza sativa L.) by white-rot fungi: Effects on structure, chemical composition, cell wall components and nutrient digestibility in vitro. [D] . Karunanandaa, Kanthasamy. 1995

机译：白腐真菌对稻草（Oryza sativa L.）的定殖：对体外结构，化学成分，细胞壁成分和营养消化率的影响。

6. Bacteroidaceae in Thromboembolic Disease: Effects of Cell Wall Components on Blood Coagulation In Vivo and In Vitro [O] . H. S. Bjornson, E. O. Hill 1973

机译：血栓栓塞性疾病中的拟杆菌科：细胞壁成分对体内和体外血液凝固的影响

7. Bacteroidaceae in Thromboembolic Disease: Effects of Cell Wall Components on Blood Coagulation In Vivo and In Vitro [O] . H. S. Bjornson, E. O. Hill 1973

机译：血栓栓塞疾病的菌丝：细胞壁成分对体内血液凝固的影响

8. Effects of Storage on Irradiated Red Blood Cells: An In vitro and In vivo Study [R] . Knoll, S. E. 1991

机译：储存对辐照红细胞的影响：体外和体内研究

1. 干酪乳杆菌LC2W细胞壁组分体外对巨噬细胞活性的影响 [J] . 余叶红 ,郭本恒 ,吴正钧 . 华北农学报 . 2008,第0z2期

2. 干酪乳杆菌LC2W细胞壁组分体外对巨噬细胞活性的影响 [J] . 余叶红 ,郭本恒 ,吴正钧 . 华北农学报 . 2008,第B10期

3. 丙酸杆菌细胞壁骨架体外对小鼠免疫机能的影响 [J] . 明建扩 ,陈祖琼 . 济宁医学院学报 . 1993,第002期

4. 不同醇沉竹荪多糖组分对青春双歧杆菌体外增殖作用的影响 [J] . 黄庆斌 ,郑志昌 ,陈竟豪 . 食品工业科技 . 2020,第004期

5. 青春双歧杆菌细胞壁的免疫调节和体内抑瘤作用研究 [J] . 郭俊杰 ,梁国光 ,李朝品 . 牡丹江医学院学报 . 2006,第003期

6. 肠杆菌科细菌在体内获得碳青霉烯类耐药的机制研究 [C] . 丁百兴 ,沈震 ,叶美萍 . 中国医药教育协会感染疾病专业委员会第二届学术大会、第八届全国侵袭性真菌病实验室诊断及临床治疗新进展研讨会暨2016中国药学会药物临床评价研究专业委员会年会 . 2016

7. RNAi抑制HIF-1α的表达对MCF-7细胞MTX药物敏感性和裸鼠体内成瘤性的影响及对hADAS细胞体外向内皮细胞分化影响的初步研究 [A] . 李静 . 2006

1. 双歧杆菌细胞壁和双歧杆菌细胞壁蛋白在制药中的应用 [P] . 中国专利： CN1433811A . 2003-08-06

2. 组织工程皮肤种子表皮角质形成细胞高拟体内细胞外基质附着体外筛选培养方法 [P] . 中国专利： CN105238740A . 2016-01-13

3. compound or a pharmaceutically acceptable salt or hydrolysable ester thereof in vivo, process for preparing it, pharmaceutical composition, use of a compound or pharmaceutically acceptable salt or hydrolysable ester thereof in vivo, and methods for producing a cell cycle inhibitory effect, cell proliferation in a warm-blooded animal to treat a disease, to treat cancer in a warm-blooded animal and to produce a cdk inhibitory effect on a warm-blooded animal [P] . 外国专利： BRPI0507351A . 2007-07-03

机译：化合物或其药学上可接受的盐或可水解酯在体内，其制备方法，药物组合物，化合物或其药学上可接受的盐或在体内水解酯的用途以及在体内产生细胞周期抑制作用，细胞增殖的方法温血动物，用于治疗疾病，治疗温血动物中的癌症以及对温血动物产生cdk抑制作用

4. COMPOUND, PHARMACEUTICAL COMPOSITION, METHODS FOR PREPARING A PHARMACEUTICAL COMPOSITION, TO TREAT A DISEASE, DISORDER OR CONDITION, TO INHIBIT TACE IN A CELL, IN VITRO OR IN VIVO, AND TO REGULATE (FOR EXAMPLE, INIBIT) EXAMPLE, TNF-ALPHA RELEASE) IN A CELL, IN VITRO OR IN VIVO, USE OF A COMPOUND, AND, KIT [P] . 外国专利： BRPI0811651A2 . 2014-11-11

机译：化合物，药物组合物，制备药物组合物，在体外或体内治疗疾病，疾病或病症，抑制细胞中TACE的方法，以及调节（例如，INIBIT）示例，TNF-α释放的方法在细胞内，体外或体内使用化合物和试剂盒

5. compound, pharmaceutical composition, methods for preparing a pharmaceutical composition, for inhibiting raf activity in a cell, in vitro or in vivo, for inhibiting cell proliferation, in vitro or in vivo, and for treating a disease or condition, and, use of a compound [P] . 外国专利： BRPI0710808A2 . 2012-01-31

机译：化合物，药物组合物，制备药物组合物，体外或体内抑制raf活性，体外或体内抑制细胞增殖以及治疗疾病或病症的方法，以及药物的用途复合

相关主题

Bacteroidaceae in Thromboembolic Disease: Effects of Cell Wall Components on Blood Coagulation In Vivo and In Vitro

摘要

著录项

相似文献

相关主题

期刊订阅